Lynn A. Tetrault, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 37,000 shares at $100.32 ($3.7M) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Scheduled sale ($3.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NEO | BUY | 2025-05-09 | $114K | — | Filing → |
| RYTM | SELL | 2024-09-11 | $2.0M | — | Filing → |
| RYTM | SELL | 2024-08-28 | $215K | — | Filing → |